Amphetamine News and Research

RSS

OnDosis and Adare Pharma Solutions announce strategic collaboration to advance OnDosis's lead U.S. ADHD program

OnDosis AB ("OnDosis"), a Swedish life science company developing drug device combinations for precision dosing of oral solid medicines based on the Dosage Manager device platform, and Adare Pharma Solutions ("Adare"), a technology-driven, integrated contract development and manufacturing organization (CDMO), today announced a strategic collaboration.

From OnDosis AB 1 Oct 2026

Cannabis, cocaine and amphetamines linked to higher stroke risk

Cannabis and other illicit drugs are associated with higher stroke risk, underscoring the importance of addressing substance use disorders in health strategies.

11 Mar 2026

ADHD prescriptions surged during the COVID-19 pandemic

A study reveals COVID-19 reshaped stimulant prescribing patterns in Ontario, highlighting increased ADHD diagnoses and concerns over treatment appropriateness.

11 Mar 2026

Recreational drugs significantly increase the risk of stroke

The recreational drugs cannabis, cocaine and amphetamines significantly increase the risk of stroke – including among younger users – Cambridge researchers have concluded after analyzing data from more than 100 million people.

9 Mar 2026

Unprescribed Adderall causes significant cardiovascular effects in young adults

A Mayo Clinic study found that a single 25 mg dose of a combination of amphetamine-dextroamphetamine salts (Adderall) can have measurable cardiovascular effects in healthy young adults.

2 Mar 2026

How GLP-1 drugs affect the body beyond weight loss and glucose control

This review evaluates the safety profile of glucagon-like peptide-1 receptor agonists and related incretin therapies used for obesity and type 2 diabetes. It highlights common gastrointestinal effects, rare but debated risks, and areas where further long-term safety data are still needed.

18 Feb 2026

Global drug addiction mortality rates double despite fewer new cases

The global drug use disorder deaths have more than doubled since 1990, even as new addiction cases declined, highlighting a widening gap in harm reduction and treatment access, especially in wealthy nations.

15 Oct 2025

Khat use linked to autoimmune hepatitis in young men

Khat (Catha edulis), a plant chewed for its stimulant effects by millions in East Africa and the Arabian Peninsula, is increasingly recognized for its hepatotoxic potential.

30 Sep 2025

Chronically ill? In Kennedy’s view, it might be your own fault

On a recent weekday evening, Ashly Richards helped her 13-year-old son, Case, with homework. He did math problems and some reading, underscoring how much he's accomplished at his school for children with autism.

31 Jul 2025

Stimulant use quietly drives rise in opioid-related deaths

Many people might be aware of an ongoing opioid epidemic, with thousands of people dying every year from overdoses.

16 Jul 2025

FAU neuroscientist receives NIH grant to study amphetamine effects on the brain

Lucia Carvelli, Ph.D., associate professor of neuroscience at Florida Atlantic University's Harriet L. Wilkes Honors College and a member of the FAU Stiles-Nicholson Brain Institute, has received a $571,675 grant from the National Institutes of Health to advance critical research into how amphetamines affect brain function.

15 Jul 2025

High fructose diets impair brain function and appetite control, study shows

Review highlights how excessive fructose intake disrupts brain energy balance, appetite regulation, and cognitive function. Processed sources, such as sugary drinks, may overwhelm metabolic pathways and induce neuroinflammation, particularly during adolescence.

30 Apr 2025